Regeneron Pharmaceuticals, Inc. (NasdaqGS:REGN) announces a share repurchase program. Under the program, the company will repurchase up to $3,000 million worth of its outstanding common stock. The program has no time limit and can be discontinued at any time.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
982.3 USD | +1.48% | +0.87% | +11.84% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.84% | 10TCr | |
+9.42% | 11TCr | |
-14.15% | 2.24TCr | |
-1.05% | 2.23TCr | |
-5.29% | 1.91TCr | |
-38.29% | 1.8TCr | |
-4.16% | 1.79TCr | |
+7.99% | 1.43TCr | |
+36.24% | 1.25TCr | |
-24.95% | 845.25Cr |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals, Inc. announces an Equity Buyback for $3,000 million worth of its shares.